Stephenson Emma L, Rathert-Williams Abigail R, Kenny Ann L, Nagy Dusty W, Shoemake Brian M, McFadden Thomas B, Tucker Heather A, Meyer Allison M
Division of Animal Sciences, University of Missouri, Columbia, MO 65211, USA.
School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.
Transl Anim Sci. 2023 Aug 16;7(1):txad097. doi: 10.1093/tas/txad097. eCollection 2023.
To determine effects of Cu, Zn, and Mn source and inclusion during late gestation, multiparous beef cows [ = 48; 649 ± 80 kg body weight (BW); 5.3 ± 0.5 body condition score (BCS)] were individually-fed hay and supplement to meet or exceed all nutrient recommendations except Cu, Zn, and Mn. From 91.2 ± 6.2 d pre-calving to 11.0 ± 3.2 d post-calving, cows received: no additional Cu, Zn, or Mn (control, CON), sulfate-based Cu, Zn, and Mn (inorganic, ITM) or metal methionine hydroxy analogue chelates (MMHAC) of Cu, Zn, and Mn at 133% recommendations, or a combination of inorganic and chelated Cu, Zn, and Mn (reduce and replace, RR) to meet 100% of recommendations. Data were analyzed with treatment and breeding group (and calf sex if < 0.25 for offspring measures) as fixed effects, animal as experimental unit, and sampling time as a repeated effect for serum, plasma, and milk measures over time. Post-calving cow liver Cu was greater (≤ 0.07) in MMHAC compared with all other treatments. Calves born to RR had greater (≤ 0.05) liver Cu than ITM and CON, and MMHAC had greater (= 0.06) liver Cu than CON. Liver Mn was less (≤ 0.08) for RR calves than all other treatments. Calf plasma Zn was maintained (≥ 0.15) from 0 to 48 h of age in ITM and MMHAC but decreased (≤ 0.03) in CON and RR. Gestational cow BW, BCS, and metabolites were not affected (≥ 0.13) by treatment, but gestational serum thiobarbituric acid reactive substances (TBARS) were greater (= 0.01) for CON than MMHAC. Treatment did not affect (≥ 0.13) calf birth size, vigor, placental size and minerals, or transfer of passive immunity. Neonatal calf serum Ca was greater (≤ 0.05) for MMHAC than all other treatments; other calf serum chemistry and plasma cortisol were not affected (≥ 0.12). Pre-suckling colostrum yield, and lactose concentration and content, were greater (≤ 0.06) for MMHAC compared with ITM and RR. Colostral triglyceride and protein concentrations were greater (≤ 0.08) for RR than MMHAC and CON. Cow lactational BW and BCS, milk yield and composition, and pre-weaning calf BW and metabolism were not affected (≥ 0.13) by treatment. Lactational serum TBARS were greater (= 0.04) for RR than CON at day 35 and greater (≤ 0.09) for MMHAC at day 60 than all other treatments. Source and inclusion of Cu, Zn, and Mn altered maternal and neonatal calf mineral status, but calf size and vigor at birth, passive transfer, and pre-weaning growth were not affected in this study.
为了确定妊娠后期铜、锌和锰的来源及添加量的影响,选用48头经产肉用母牛[体重(BW)649±80千克;体况评分(BCS)5.3±0.5],单独饲喂干草并补充饲料,以满足或超过除铜、锌和锰之外的所有营养推荐量。从产前91.2±6.2天至产后11.0±3.2天,母牛接受以下处理:不额外添加铜、锌或锰(对照组,CON);以硫酸盐形式添加铜、锌和锰(无机组,ITM)或按推荐量的133%添加铜、锌和锰的蛋氨酸羟基类似物金属螯合物(MMHAC);或添加无机和螯合形式的铜、锌和锰的组合(减少并替代组,RR)以满足100%的推荐量。数据以处理组、繁殖组(如果后代测量值<0.25,则包括犊牛性别)为固定效应,动物为实验单位,采样时间为血清、血浆和乳汁随时间变化测量的重复效应进行分析。产后母牛肝脏铜含量在MMHAC组中高于所有其他处理组(≤0.07)。RR组出生的犊牛肝脏铜含量高于ITM组和CON组(≤0.05),MMHAC组的肝脏铜含量高于CON组(=0.06)。RR组犊牛肝脏锰含量低于所有其他处理组(≤0.08)。ITM组和MMHAC组犊牛血浆锌在0至48小时龄时保持稳定(≥0.15),而CON组和RR组则下降(≤0.03)。妊娠母牛的体重、体况评分和代谢产物不受处理的影响(≥0.13),但妊娠血清硫代巴比妥酸反应物质(TBARS)在CON组中高于MMHAC组(=0.01)。处理对犊牛出生大小、活力、胎盘大小和矿物质含量或被动免疫转移没有影响(≥0.13)。MMHAC组新生犊牛血清钙含量高于所有其他处理组(≤0.05);其他犊牛血清化学指标和血浆皮质醇不受影响(≥0.12)。与ITM组和RR组相比,MMHAC组的初乳产量、乳糖浓度和含量更高(≤0.06)。RR组初乳甘油三酯和蛋白质浓度高于MMHAC组和CON组(≤0.08)。母牛泌乳期体重、体况评分、产奶量和组成以及断奶前犊牛体重和代谢不受处理的影响(≥0.13)。泌乳期血清TBARS在第35天时RR组高于CON组(=0.04),在第60天时MMHAC组高于所有其他处理组(≤0.09)。铜、锌和锰的来源及添加量改变了母畜和新生犊牛的矿物质状况,但本研究中犊牛出生时的大小和活力、被动转移和断奶前生长未受影响。